Shubha Ananthakrishnan is a Nephrology physician affiliated with UC Davis Health. OpenAlex indexes 28 publications with 287 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4150 V St
#3500
Sacramento, CA 958171460
Telephone
916-734-3774Registry record last updated 8 Nov 2011.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Vantive US Healthcare LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
55.2%Angiotensin receptor blocker (ARB)14.3%Losartan Potassium64%Telmisartan14%Valsartan11%Olmesartan Medoxomil11%Part D<11 patientsCalcium channel blocker14.1%Amlodipine Besylate89%Nifedipine Er11%Part D<11 patients+ 5 more classes in this area
Other
21.5%Drugs for treatment of hyperkalemia and hyperphosphatemia12.7%Velphoro50%Lokelma38%Auryxia13%Part D<11 patientsPhosphate Binder8.8%Sevelamer Carbonate100%Part D≥17 patientsMetabolism & gastrointestinal
16.6%SGLT2 inhibitor9.9%Jardiance66%Farxiga34%Part D<11 patientsVitamin D3 Analog4.9%Calcitriol100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Tubulointerstitial Nephritis and Uveitis in Pregnancy: A Diagnostic Dilemma
Journal of the American Society of Nephrology
2025 - Hyponatremia, mg vs. mEq Gone Terribly Wrong: A Cautionary Tale
Journal of the American Society of Nephrology
2024 - Embedded Peritoneal Dialysis Catheter: When Things Go Wrong
Journal of the American Society of Nephrology
2024 - A Viral Conundrum: Hepatitis D and Immune-Complex Glomerulonephritis
Journal of the American Society of Nephrology
2024 - IgA Glomerulonephritis in the Setting of Immune Checkpoint Inhibitor Use Successfully Treated with Rituximab
Journal of the American Society of Nephrology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Donald Hilty, MD, MBA
UC Davis Health
William Pevec, MD
UC Davis Health
Ankit Sarin, MD, MHA
UC Davis Health
Lin Zhang
UC Davis Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”